This Week's CGT News: First Treg Therapy Approved
July 7, 2026
First Treg-based cell therapy approved, FDA advanced therapy office faces fresh turnover, and preclinical CAR T studies target rare blood cancers and glioblastoma
5 min read
False
Advertisement
Cell & Gene
Roving Reporter Asks: How Are CGT Companies Rethinking Pricing and Reimbursement?
July 7, 2026
IBTV speaks with industry leaders at ARM’s Meeting on the Med 2026 to explore how cell and gene therapy companies are approaching pricing, reimbursement, and access as more potentially curative therapies reach patients
1 min read
AI Framework Helps Identify New CAR T Target
July 6, 2026
A human-in-the-loop AI strategy helped narrow more than 10,000 candidates to a CAR T target now validated in mouse models
2 min read
CAR T Cells Target TNF in Mouse Model of Rheumatoid Arthritis
June 30, 2026
A single infusion of engineered T cells degraded soluble TNF and produced durable disease control in mice
2 min read
Why Early QC Planning Matters in Cell and Gene Therapy
By Laurent Claisse
June 30, 2026
Late-stage CMC setbacks often begin with early QC decisions that shape cell and gene therapy timelines, costs, and regulatory outcomes
7 min read
Cell & Gene
Development & Clinical
Outsourcing
Regulation & Standards
Business & Trends
Technology & Manufacturing
Roving Reporter Asks: What Are Recent Breakthroughs Telling Us About the CGT Field’s Maturity?
June 25, 2026
IBTV speaks with industry leaders at ARM’s Meeting on the Med 2026 to explore what recent clinical, regulatory, and commercial milestones reveal about the next phase of cell and gene therapy
This Week’s CGT News: Gene Therapy Extends Health Span in Mice
June 23, 2026
A gene therapy preserves organ function and boosts life expectancy in mice, while base editing avoids some CRISPR damage in human embryos, and immune clues emerge for CAR T in glioblastoma
4 min read
In Vivo CRISPR Therapy Succeeds in Phase 3 Trial
June 22, 2026
A single infusion of Intellia’s in vivo gene-editing therapy reduced monthly hereditary angioedema attacks by 87 percent
3 min read
Collaboration is the Key to Democratizing Advanced Therapies
By Aaron Dulgar-Tulloch
June 17, 2026
Why no single player can solve the scalability challenge alone
4 min read
